ZA939633B - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
ZA939633B
ZA939633B ZA939633A ZA939633A ZA939633B ZA 939633 B ZA939633 B ZA 939633B ZA 939633 A ZA939633 A ZA 939633A ZA 939633 A ZA939633 A ZA 939633A ZA 939633 B ZA939633 B ZA 939633B
Authority
ZA
South Africa
Prior art keywords
folic acid
pharmaceutical compounds
competitive
leucovorin
administration
Prior art date
Application number
ZA939633A
Other languages
English (en)
Inventor
Gary Keith Smith
David Stanley Duch
Robert Ferone
Arthur Koch
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA939633B publication Critical patent/ZA939633B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA939633A 1992-12-23 1993-12-22 Pharmaceutical compounds ZA939633B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226842A GB9226842D0 (en) 1992-12-23 1992-12-23 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
ZA939633B true ZA939633B (en) 1995-06-22

Family

ID=10727128

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA939633A ZA939633B (en) 1992-12-23 1993-12-22 Pharmaceutical compounds

Country Status (15)

Country Link
US (3) US6358952B1 (xx)
EP (1) EP0675719B1 (xx)
JP (1) JP3774850B2 (xx)
KR (1) KR100296643B1 (xx)
AT (1) ATE167058T1 (xx)
AU (1) AU676252B2 (xx)
CA (1) CA2152507C (xx)
DE (1) DE69319141T2 (xx)
ES (1) ES2117245T3 (xx)
GB (1) GB9226842D0 (xx)
IL (1) IL108139A0 (xx)
MX (1) MX9400215A (xx)
TW (1) TW340044B (xx)
WO (1) WO1994014448A1 (xx)
ZA (1) ZA939633B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds
DE10062401A1 (de) * 2000-12-14 2002-06-20 Beiersdorf Ag Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA
US7547964B2 (en) * 2005-04-25 2009-06-16 International Rectifier Corporation Device packages having a III-nitride based power semiconductor device
US8501242B2 (en) * 2009-05-29 2013-08-06 University Of Florida Research Foundation Methods and compositions for treating neoplasia
CN101580501B (zh) 2009-06-01 2011-03-09 南京卡文迪许生物工程技术有限公司 3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
US5217974A (en) 1991-03-29 1993-06-08 Eli Lilly And Company Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity
AU640524B2 (en) * 1991-03-29 1993-08-26 Eli Lilly And Company Use of folic acid for reducing the toxicity of antitumour antifolate agents and methods for treating tumours
GB9119700D0 (en) 1991-09-14 1991-10-30 Int Computers Ltd Cryptographic facility for a data processing system
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds

Also Published As

Publication number Publication date
KR100296643B1 (ko) 2001-10-22
EP0675719B1 (en) 1998-06-10
WO1994014448A1 (en) 1994-07-07
KR950703963A (ko) 1995-11-17
JP3774850B2 (ja) 2006-05-17
US6358952B1 (en) 2002-03-19
AU5708494A (en) 1994-07-19
US6579877B2 (en) 2003-06-17
ES2117245T3 (es) 1998-08-01
US20030203924A1 (en) 2003-10-30
GB9226842D0 (en) 1993-02-17
DE69319141D1 (de) 1998-07-16
US6855712B2 (en) 2005-02-15
AU676252B2 (en) 1997-03-06
MX9400215A (es) 1994-07-29
US20020137748A1 (en) 2002-09-26
JPH08504800A (ja) 1996-05-28
ATE167058T1 (de) 1998-06-15
CA2152507C (en) 2005-10-18
TW340044B (en) 1998-09-11
EP0675719A1 (en) 1995-10-11
DE69319141T2 (de) 1998-10-08
CA2152507A1 (en) 1994-07-07
IL108139A0 (en) 1994-04-12

Similar Documents

Publication Publication Date Title
EP0497258A3 (en) Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer
IL101145A0 (en) Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives
AU576563B2 (en) Pyridazine derivatives
EP0513702A3 (en) Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
PH30132A (en) 1-Substituted 1H-imidazo-[4,5-c]quinolin-4-amines
TW376319B (en) Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
CA2058428A1 (en) Analgesic formulations
TW355683B (en) Composition containing micronized nebivolol
EP0612248A4 (en) Combination chemotherapy.
TW234691B (xx)
GB8904163D0 (en) Piperazine derivative or its sait,process for producing the same and pharmaceutical composition comprising the same as active ingredient
WO2000045800A3 (en) Immunosurpressive effects of pteridine derivatives
IE873125L (en) Benzimidazole derivatives
EP0620004A4 (en) MEDICAL COMPOSITION.
GB9226842D0 (en) Pharmaceutical compounds
HUT62760A (en) Nematocidal compositions comprising pyrimidine derivatives as active ingredient and process for producing the active ingredient
CZ123595A3 (en) The use of xanthine derivatives for preparing pharmaceutical preparations and pharmaceutical compositions containing said derivatives
HUT67287A (en) Piperazynil camphor derivatives and pharmaceutical compositions containing them
TW366284B (en) Pharmaceutical antitussive composition of delta-receptor antagonist
WO2000056295A3 (en) Oral combinations of hydroxocobalamin and folic acid
ES8504774A1 (es) Procedimiento para preparar derivados de 2-piperacinil-quinazolina
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
EP0523013A3 (en) Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases
ZA947401B (en) Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles